Ascendis Health : Dispensation Received on 60 Day Rule to Dispatch Circular

Dispensation Received on 60 Day Rule to Dispatch Circular

 Ascendis Health Limited
 (Registration number 2008/005856/06)
 (Incorporated in the Republic of South Africa)
 Share code: ASC
 ISIN: ZAE000185005
 ("Ascendis Health" or "the Company")


                     DISPENSATION RECEIVED ON 60 DAY RULE TO DISPATCH CIRCULAR



Shareholders are referred to the announcement released on 1 February 2022 regarding the proposed disposal by
Ascendis Health SA Holdings Proprietary Limited, a wholly-owned subsidiary of Ascendis Health, of its direct and indirect
interests in the entities through which the businesses known as "Pharma", "Skin" and "Medical" operate (collectively,
"the Disposals").

Shareholders are advised that the Company has, in relation to the proposed Disposals, received dispensation from
compliance with paragraph 9.20(b) of the JSE Limited Listings Requirements, which stipulates that a company must
dispatch a circular to its shareholders containing a notice of general meeting to obtain their approval for a transaction
within 60 days of the date of announcement of such transaction. Shareholders are further advised that a circular
containing details pertaining to the Disposals, as well as a notice of general meeting to obtain the approval of
shareholders for the transactions, is expected to be dispatched on or about 31 May 2022.

The board of directors of the Company ("the Board") accepts responsibility for the information contained in this
announcement as it pertains to Ascendis Health. To the best of the Board's knowledge and belief, the information
contained in this announcement as it pertains to Ascendis Health is true and nothing has been omitted which is likely to
affect the importance of such information.


5 April 2022
Bryanston

Sponsor
Questco Corporate Advisory Proprietary Limited

Date: 05-04-2022 05:10:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.